Research.Patient.info
Locally Advanced or Metastatic Urothelial Cancer research hub
2 indexed studies · 0 currently recruiting
- authorisedPhase I and Phase II (Integrated)- Other
C6461006 - An Interventional Phase 1b/2, Open-Label Study to Investigate the Safety, Antitumor Activity, and Pharmacokinetics of PF-08634404 Monotherapy or in Combination With Enfortumab Vedotin in Adult Participants With Locally Advanced or Metastatic Urothelial Cancer.
This study is testing a new medicine, PF-08634404, on its own or with an existing drug, Enfortumab Vedotin (Padcev), for adults with advanced bladder cancer. Doctors want to see if it's safe, how well it works, and how the body handles it.
Netherlands · Spain - ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
This study looks at a new drug, enfortumab vedotin, for advanced bladder or urinary tract cancer that has spread. It compares it to standard chemotherapy to see if it helps people live longer and improves their quality of life.
Portugal · Spain